Science
Mechanism of Action
It functions as a selective agonist for Cannabinoid Receptor Type 2 (CB2) within the skin's endocannabinoid system. By activating this pathway, it inhibits NF-κB and MAPK inflammatory signaling while simultaneously triggering Nrf2 antioxidant defenses and upregulating structural proteins like laminin-γ2 for rapid barrier re-epithelialization.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 Demonstrated significant acceleration in collagen synthesis and wound closure in emulgel formats (2022).
- 02 In vitro human keratinocyte assays confirmed potent reduction in inflammatory markers COX-2 and IL-1β (2024).
- 03 Identified a specific therapeutic window to prevent mast cell recruitment seen at excessive repeated dosages (2025).
Transparency
Dusting Analysis
Often included at trace levels for its spicy scent profile; however, therapeutic anti-inflammatory and wound-healing benefits require concentrations closer to 1%. It is a 'red flag' if used below 0.001% in leave-on products while being marketed for its CB2-targeting medicinal properties.
The Formula
Formulation
Stability
Highly volatile and sensitive to oxidation. Exposure to air converts it into beta-caryophyllene oxide (BCPO), a potent sensitizer; requires opaque, airtight packaging and stabilization with antioxidants like Tocopherol.
Synergies
- Cannabidiol (CBD)
- Tocopherol (Vitamin E)
- Lipid-rich carrier oils
Conflicts
- Oxidizing agents
- High-oxygen environments
- Strongly alkaline environments (pH > 10.5)
Safety
Safety Profile
While safe up to 2%, it is a recognized EU allergen. Freshness is critical: oxidized material (BCPO) is the primary driver of skin sensitization.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A potent, science-backed phyto-cannabinoid for barrier repair, provided it is stabilized against oxidation and dosed with precision.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources